These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4973676)

  • 21. [Experimental evolution of mycobacteria to "L" forms in vivo].
    Gaiginschi A; Luca D; Radu GC
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):385-93. PubMed ID: 4999242
    [No Abstract]   [Full Text] [Related]  

  • 22. Rifampicin activity "in vitro" and in established tuberculosis in mice.
    Verbist L
    Acta Tuberc Pneumol Belg; 1969; 60(3):397-412. PubMed ID: 4984420
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tuberculostatic activity of various rifampicin derivatives in vitro and in vivo].
    Kochanova NK; Miakotina EN; Bellendir EN; Boiarkina SK; Iudelevich VI
    Probl Tuberk; 1983 Jun; (6):65-8. PubMed ID: 6410375
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of pulsed exposures to rifampin on the uptake of uridine- 14 C by Mycobacterium tuberculosis.
    Dickinson JM; Jackett PS; Mitchison DA
    Am Rev Respir Dis; 1972 Apr; 105(4):519-27. PubMed ID: 4622857
    [No Abstract]   [Full Text] [Related]  

  • 25. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
    Yan BS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
    [No Abstract]   [Full Text] [Related]  

  • 26. [The virulence of Mycobacterium tuberculosis strains resistant to rifampicin. (Preliminary note)].
    Daddi G; Lucchesi M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(1):29-33. PubMed ID: 4996681
    [No Abstract]   [Full Text] [Related]  

  • 27. [Study of the biological characteristics of strains of M. tuberculosis resistant to isoniazid and rifampin].
    Diaconescu C; Iacob L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1984; 33(2):151-62. PubMed ID: 6093222
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of the development of rifomycin blood levels in humans by 2 different microbiologic methods].
    Canetti G; Djurovic V; Le Lirzin M; Thibier R; Lepeuple A
    Rev Tuberc Pneumol (Paris); 1970; 34(1):93-106. PubMed ID: 4996249
    [No Abstract]   [Full Text] [Related]  

  • 29. [Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by means of Rifamycin SV susceptibility].
    Tsukamura M; Tsukamura S
    Igaku To Seibutsugaku; 1966 Jun; 72(6):350-2. PubMed ID: 4959327
    [No Abstract]   [Full Text] [Related]  

  • 30. [The antimycobacterial activity of rifamycin B diethylamide].
    Nitti V; Ninni A; Centrella G
    Arch Tisiol Mal Appar Respir; 1966 May; 21(5):359-69. PubMed ID: 5297199
    [No Abstract]   [Full Text] [Related]  

  • 31. [The activity of Rifampicin in vitro on atypical mycobacteria].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1967 May; 22(5):498-506. PubMed ID: 4975206
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antitubercular effect of ethionamide in vitro and in experimental tuberculosis].
    Bialik IB
    Mikrobiol Zh; 1966; 28(5):65-70. PubMed ID: 4966793
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rifampicin sensitivity of mycobacteria].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(1):17-28. PubMed ID: 4996680
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli].
    Fabbrocini V
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):435-40. PubMed ID: 4984548
    [No Abstract]   [Full Text] [Related]  

  • 35. Experimental observations on the antimycobacterial activity of rifampin.
    Hobby GL LENERT TF; Maier-Engallena J
    Proc Soc Exp Biol Med; 1969 Jun; 131(2):323-6. PubMed ID: 4977745
    [No Abstract]   [Full Text] [Related]  

  • 36. The antimycobacterial activity of rifampicin "in vitro".
    Zierski M; Wozniak S; Tomaszkiewicz L
    Acta Tuberc Pneumol Belg; 1969; 60(3):341-7. PubMed ID: 4984417
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug-resistant Mycobacterium tuberculosis].
    Iwasaki I
    Naika; 1965 Jul; 16(1):58-61. PubMed ID: 4957093
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimycobacterial activity of rifaximin (L/105) in experimental tuberculosis in the guinea pig.
    Lucchesi M; Marchi E; Venturini AP
    Chemioterapia; 1984 Dec; 3(6):371-2. PubMed ID: 6442216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.